Covaxin trials News
WHO Chief Scientist Dr Soumya Swaminathan said that the data from the phase 3 trial of Bharat Biotech’s vaccine Covaxin looks good.
Dr Soumya Swaminathan said, “We keep a close eye on all vaccines which have received emergency use listing. We continue to seek more data."
AIIMS Delhi will start Covaxin trials on children in few days, say sources
AIIMS Patna has already started trials in the age of 12-18 years
Union Health Minister Harsh Vardhan on December 19 had said that country`s scientists and health experts have worked on the development of an indigenous vaccine
In the upcoming six to seven months, India will have the capacity to inoculate about 30 crore people
The six vaccine candidates which are in various stages of the clinical trial are - Covishield, Covaxin, ZyCoV-D, Sputnik V, NVX-CoV2373
The ICMR on Saturday said that the process to develop an indigenous vaccine to fight the coronavirus pandemic is as per globally accepted norms of fast-tracking and that the safety and interest of people of India the topmost priority.
Loading...